Show source-provided references
4. Erasure of the processing effects in polyamide 6 based cast films by the introduction of montmorillonite: Effect on water and oxygen transport properties
10.1016/j.memsci.2014.01.018 ↗5. Polyamides and their functionalization: Recent concepts for their applications as biomaterials
10.1039/C7BM00160F ↗6. Grumezescu, A.M., and Holban, A.M. (2018). Chapter 12—Microbial Polyamino Acids: An Overview for Commercial Attention. Role of Materials Science in Food Bioengineering, Academic Press.
8. Design and synthesis of new s-triazine polymers and their application as nanoparticulate drug delivery systems
10.1039/C6NJ02539K ↗12. Patravale, V., Dandekar, P., and Jain, R. (2012). Clinical trials industrial aspects. Nanoparticulate Drug Delivery, Woodhead Publishing.
10.1533/9781908818195 ↗13. Simmons, P., McElroy, T., and Allen, A.R. (2020). A Bibliometric Review of Artificial Extracellular Matrices Based on Tissue Engineering Technology Literature: 1990 through 2019. Materials, 13.
10.3390/ma13132891 ↗14. Polymers as Biomaterials for Tissue Engineering and Controlled Drug Delivery
15. Small changes in polymer chemistry have a large effect on the bone–implant interface: Evaluation of a series of degradable tyrosine-derived polycarbonates in bone defects
10.1016/S0142-9612(99)00151-9 ↗16. Osteogenic Differentiation of Pre-Osteoblasts on Biomimetic Tyrosine-Derived Polycarbonate Scaffolds
10.1021/bm200700d ↗17. Poly(amino acid)s/polypeptides as potential functional and structural materials
10.1038/pj.2015.35 ↗18. Sol-gel production of bioactive nanocoatings for medical applications. Part II: Current research and development
10.2217/17435889.2.1.51 ↗20. Poly(aspartic-acid) derivatives as polymeric micelle drug delivery systems
10.1002/app.23353 ↗21. PEG-g-poly(aspartamide-co-N,N-dimethylethylenediamino aspartamide): Synthesis, characterization and its application as a drug delivery system
10.1016/j.pnsc.2009.02.008 ↗22. Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: Preparation, characterization and the use for 5-fluorouracil delivery
10.1016/j.ejpb.2007.04.007 ↗23. Conjugation of Arginine-Glycine-Aspartic Acid Peptides to Poly(ethylene oxide)-b-poly(ε-caprolactone) Micelles for Enhanced Intracellular Drug Delivery to Metastatic Tumor Cells
10.1021/bm060967g ↗26. pH-Responsive Self-Assembly and conformational transition of partially propyl-esterified poly(α,β-l-aspartic acid) as amphiphilic biodegradable polyanion
10.1016/j.colsurfb.2008.08.026 ↗29. Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer
10.1016/j.jsps.2014.11.010 ↗30. Self-Propelled and Targeted Drug Delivery of Poly(aspartic acid)/Iron–Zinc Microrocket in the Stomach
35. Transfection of Folate-Polylysine DNA Complexes: Evidence for Lysosomal Delivery
10.1021/bc00035a002 ↗36. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels
10.1073/pnas.87.11.4033 ↗37. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake
10.1073/pnas.91.9.4086 ↗40. Target-Specific Cellular Uptake of PLGA Nanoparticles Coated with Poly(l-lysine)−Poly(ethylene glycol)−Folate Conjugate
10.1021/la0502084 ↗41. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo
10.1080/10717544.2018.1461957 ↗43. Functions of poly-gamma-glutamic acid (γ-PGA) degradation genes in γ-PGA synthesis and cell morphology maintenance
10.1007/s00253-014-5729-0 ↗46. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
10.1038/sj.bjc.6602772 ↗47. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice
49. A new class of polymerizable dextrans with hydrolyzable groups: Hydroxyethyl methacrylated dextran with and without oligolactate spacer
10.1016/S0032-3861(97)00189-4 ↗52. FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier
10.1021/am505441p ↗53. Enhancement of efficiency of chitosan-based complexes for gene transfection with poly(γ-glutamic acid) by augmenting their cellular uptake and intracellular unpackage
10.1016/j.jconrel.2014.04.024 ↗54. Anti-inflammatory Chitosan/Poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc
10.1016/j.actbio.2016.06.013 ↗55. Nanoencapsulation of red ginseng extracts using chitosan with polyglutamic acid or fucoidan for improving antithrombotic activities
10.1021/acs.jafc.6b00911 ↗56. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin
10.1016/j.actbio.2015.06.021 ↗57. Yan, X., Tong, Z., Chen, Y., Mo, Y., Feng, H., Li, P., Qu, X., and Jin, S. (2017). Bioresponsive Materials for Drug Delivery Based on Carboxymethyl Chitosan/Poly(γ-Glutamic Acid) Composite Microparticles. Mar. Drugs, 15.
10.3390/md15050127 ↗58. Tekade, R.K. (2019). Chapter 4—Use of Polymers in Controlled Release of Active Agents. Basic Fundamentals of Drug Delivery, Academic Press.
60. Synthesis of a Novel Dendritic Liquid Crystalline Polymer Showing a Ferroelectric SmC* Phase
10.1021/ja9813562 ↗61. Homogeneous catalysts based on silane dendrimers functionalized with arylnickel(II) complexes
10.1038/372659a0 ↗65. Starburst Dendrimers—Molecular-Level Control of Size, Shape, Surface-Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter
67. Florendo, M., Figacz, A., Srinageshwar, B., Sharma, A., Swanson, D., Dunbar, G.L., and Rossignol, J. (2018). Use of Polyamidoamine Dendrimers in Brain Diseases. Molecules, 23.
10.3390/molecules23092238 ↗68. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins
10.1016/j.ijpharm.2005.07.023 ↗74. In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells
10.1016/j.ijpharm.2017.06.026 ↗75. Fatty Acid Based Polyamide for Application in Drug Delivery System: Synthesis, Characterization, Drug Loading and In Vitro Drug Release Study
10.1007/s10904-020-01512-x ↗77. 5-Phenyl-1,3,4-oxadiazole-2-thiol/polyamide-montmorillonite microbicides nanocomposites as drug delivery system
10.1002/poc.3834 ↗78. Clathrin-Independent Killing of Intracellular Mycobacteria and Biofilm Disruptions Using Synthetic Antimicrobial Polymers
10.1021/acs.biomac.7b00106 ↗79. Hesperetin-loaded lipid-core nanocapsules in polyamide: A new textile formulation for topical drug delivery
10.2147/IJN.S124564 ↗80. Multi-Layered Polyamide/Collagen Scaffolds with Topical Sustained Release of N-Acetylcysteine for Promoting Wound Healing
10.2147/IJN.S232190 ↗81. In Vitro Evaluation of a Targeted and Sustained Release System for Retinoblastoma Cells Using Doxorubicin as a Model Drug
10.1089/jop.2010.0048 ↗84. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
10.1016/j.addr.2012.10.002 ↗87. Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
10.3390/nano5041690 ↗90. Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose-limiting
10.1200/JCO.1993.11.10.2010 ↗91. Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: An active regimen with limiting neurotoxicity
10.1200/JCO.1996.14.7.1993 ↗92. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
10.1038/sj.bjc.6602479 ↗95. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
10.1016/0168-3659(90)90139-K ↗96. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood
98. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel
10.1038/sj.bjc.6603311 ↗99. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
10.1038/sj.bjc.6603855 ↗100. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer
10.1007/s10637-011-9709-2 ↗